KIT and small cell lung carcinoma: The molecular pathology of more than 70% of SCLC cases involves autocrine stimulation due to the coexpression of c-kit and its ligand stem cell factor (SCF) (Hibi et al, 1991), and high c-kit expression level is associated with a poor prognosis (Micke et al, 2003).